Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/26831
DC FieldValueLanguage
dc.contributor.authorSotirova, Tatjanaen_US
dc.contributor.authorStojanovikj, Aleksandaren_US
dc.contributor.authorGenadieva stavrikj, Sonjaen_US
dc.contributor.authorKaranfilski, Oliveren_US
dc.contributor.authorKrstevska balkanov, Svetlanaen_US
dc.contributor.authorPavkovikj, Maricaen_US
dc.contributor.authorTrpkovska Terzieva, Slobodankaen_US
dc.date.accessioned2023-06-15T08:07:27Z-
dc.date.available2023-06-15T08:07:27Z-
dc.date.issued2015-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/26831-
dc.description.abstractBackground: Accurate prediction of a patient’s prognosis is useful to define the risk posed by the disease. Age, gender, peripheral blood cytopenias, proportion of bone marrow (BM) blasts, performance status, comorbidities, transfusion dependence, specific karyotype abnormalities and molecular biomarkers can refine the prediction of prognosis in MDS. Aim: to assess the influence of the some prognostic factors like age, gender, cytopenias, BM blast percentage, transfusion dependence, ferritin, hemoglobin (Hb), lactate dehydrogenase (LDH), albumin and specific karyotype abnormalities in myelodysplastic syndromes on overall survival (OS). Patients and Methods: we retrospectively analyzed the cohort of 108 patients diagnosed between 1.1.2011 and 31.12.2013 at the University Clinic of Hematology, Ss Cyril and Methodius University, Skopje, Macedonia. They were evaluated for clinical and hematologic features at diagnosis and at leukemic transformation. Results: in the study group 62 were man and 46 women. Male to female ratio was 1.35 to 1. The differences in OS between men and women were significant (p =.03015). The mean age at diagnosis was 66,6 years. According to the age OS was 16,4 months. FAB subtypes influenced OS significantly (p =.03015). OS inversely correlated with BM blast percentage (p=.02327). Cytopenias had no impact on OS (p=.33755). Hb as a whole and groups with different levels of Hb had no influence on OS (p =.12142) and (p=.07535), respectively. The group with ferritin <500 μg/L had better OS (p=.04720). Transfusion dependence, LDH and albumin had no impact on OS. Leukemic transformation was noticed in 10 (9,3%) patients. Mortality was 36,1%. Conclusion: gender, FAB subtypes, BM blast percentage and the serum levels of ferritin had an influence on OS, while age, hemoglobin level, transfusion dependence, LDH and albumin had no impact on OS.en_US
dc.language.isoenen_US
dc.publisherTurkish Society of Hematologyen_US
dc.subjectMyelodysplastic syndromesen_US
dc.subjectprognostic factorsen_US
dc.titleINFLUENCE OF PROGNOSTIC FACTORS ON OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMESen_US
dc.typeProceeding articleen_US
dc.relation.conference5th International Congress on Leukemia – Lymphoma – Myeloma May 21 – 23, 2015 • Istanbul, Turkey Proceedings & Abstract Booken_US
dc.identifier.urlhttp://thd.org.tr/thdData/Books/1072/5th-international-congress-on-leukemia-lymphoma-myeloma.pdf-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Show simple item record

Page view(s)

36
checked on May 20, 2024

Download(s)

6
checked on May 20, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.